Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

209
Delayed Quote. Delayed CHI-X EUROPE LIMITED. - 01/23 04:55:30 pm
291.6000 DKK   +1.21%
01/23 NOVO NORDISK A/ : receives positive opinion from the European regula..
01/22 Novo Nordisk receives positive opinion from the European regulato..
01/22 NOVO NORDISK A/ : Launches Vicotza Diabetes Drug
SummaryChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on NOVO NORDISK A/S
01/23 NOVO NORDISK A/S : receives positive opinion from the European regulatory author..
01/23 NOVO NORDISK A/S : Launches new drug
01/22 Novo Nordisk receives positive opinion from the European regulatory authoriti..
01/22 NOVO NORDISK A/S : Launches Vicotza Diabetes Drug
01/20 NOVO NORDISK A/S : -Switzerland first country to launch Xultophy (IDegLira)
01/20 NOVO NORDISK A/S : Launches diabetes drug in india
01/08 NOVO NORDISK A/S : Patent Issued for Purification of Proteins Using Preparative ..
01/08 NOVO NORDISK A/S : Patent Issued for Seal for a Prefilled Medical Jet Injection ..
01/05 NOVO NORDISK A/S : Status regarding Novo Nordisk's holding of its own shares
01/04 NOVO NORDISK A/S : Drug may help fight obesity
01/01 NOVO NORDISK A/S : New Protein and Peptide Science Study Findings Recently Were ..
01/01 NOVO NORDISK A/S : Investigators from Novo Nordisk Have Reported New Data on Hor..
01/01 NOVO NORDISK A/S : New Applied Bioinformatics Findings from Novo Nordisk Describ..
2014 NOVO NORDISK A/S : Top Five Sustainability Stories of 2014
2014 Sanofi, Novo Nordisk and Eli Lily Lead the $17 Billion US Modern Insulin Indu..
2014 NOVO NORDISK A/S : Four Seasons Ball raises $119,000
2014 NOVO NORDISK A/S : to promote drug to treat obesity in United States
2014 NOVO NORDISK A/S : receives FDA approval for Saxenda for the treatment of obesit..
2014 NOVO NORDISK A/S : New Protein and Peptide Science Study Findings Recently Were ..
2014 NOVO NORDISK A/S : New Applied Bioinformatics Findings from Novo Nordisk Describ..
2014DJNOVO NORDISK A/S : Correction to Novo Nordisk Drug Article
2014DJNOVO NORDISK A/S : FDA Approves Novo Nordisk Diabetes Drug's Use to Fight Obesit..
2014 NOVO NORDISK A/S : FDA clears Novo Nordisk's weight loss drug Saxenda
2014 Novo Nordisk receives FDA approval for Saxenda(R) for the treatment of obesit..
2014 NOVO NORDISK A/S : Investigators from Novo Nordisk Have Reported New Data on Hor..
2014 NOVO NORDISK A/S : Effia Nkwanta records 250 plus diabetes annually
2014 NOVO NORDISK A/S : Local auto racing: Kimball stays with IndyCar team
2014 NOVO NORDISK A/S : Recent Findings in Gestational Diabetes Described by Research..
2014 NOVO NORDISK A/S : Launches Community Health Collaborative™ Aimed At Impro..
2014 NOVO NORDISK A/S : and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship..
2014 NOVO NORDISK A/S : Enters Into Agreement with Chip Ganassi Racing
2014 Novo Nordisk A/S - Share repurchase programme
2014 SILENCE THERAPEUTICS : Appoints Karlsson Head Of Research & Development
2014 NOVO NORDISK A/S : Brings One-Stop Diabetes Care to African Cities
2014 NOVO NORDISK A/S : Places R&D Under the Microscope
2014 NOVO NORDISK A/S : Group Launches Diabetes Centres in Edo
2014 HYBIO PHARMACEUTICAL : Patent Application Titled "Method for Solid Phase Synthes..
2014 NOVO NORDISK A/S : Findings in Bovine Serum Albumin Reported from Novo Nordisk (..
2014 NOVO NORDISK A/S : reports positive results from phase III trial of NovoEight in..
2014 NOVO NORDISK A/S : -Share repurchase programme
2014 NOVO NORDISK A/S : Strativity Presents New Customer Experience Learning Program:..
2014 PER AARSLEFF A/S : Aarsleff to build shell structure for Novo Nordisk A/S
2014 Novo Nordisk A/S - Share repurchase programme
2014 SANOFI : Drugmaker Sanofi fired her for whistleblowing over alleged kickbacks to..
2014 NOVO NORDISK A/S : Developers marketing Plainsboro office site
2014 SANOFI : fired her for whistleblowing (Paralegal)
2014 NOVO NORDISK A/S : DHF receives $200,000 grant from Novo Nordisk
2014 NOVO NORDISK A/S : Researchers from Novo Nordisk Report Recent Findings in Diabe..
2014 NOVO NORDISK A/S : to Present Hemophilia Portfolio and Pipeline Data at 56th Ame..
2014 NOVO NORDISK A/S : Share repurchase programme
2014 NOVO NORDISK A/S : Share repurchase programme
2014 NOVO NORDISK A/S : Novo Nordisk A/S - Share repurchase programme
2014 NOVO NORDISK A/S : Findings from Novo Nordisk Reveals New Findings on Hematology..
2014 NOVO NORDISK A/S : Case Study Shows Path to Lowering Costs and Improving Diabete..
2014 NOVO NORDISK A/S : Study Results from Novo Nordisk Provide New Insights into Dia..
2014 NOVO NORDISK A/S : Details Findings in Proinsulin (Changes in Glucose and Fat Me..
2014 ELI LILLY : Gets European Approval to Sell Trulicity, a Type 2 Diabetes Drug
2014 NOVO NORDISK A/S : Changes in Novo Nordisk's Executive Management
2014 NOVO NORDISK A/S : Changes in Novo Nordisk's Executive Management
2014 NOVO NORDISK A/S : Changes in Novo Nordisk's Executive Management
2014 NOVO NORDISK A/S : Grant Enables Trenton Health Team to Engage Faith-Based Organ..
2014 NOVO NORDISK A/S : Victoza gets CHMP positive opinion to treat adults with type ..
2014 NOVO NORDISK A/S : Share repurchase programme
2014 Novo Nordisk A/S - Share repurchase programme
2014 NOVO NORDISK A/S : Victoza® receives positive CHMP opinion for use in adults wit..
2014 NOVO NORDISK A/S : Patent Issued for Single-Chain Insulin
2014 NOVO NORDISK A/S : Patent Issued for Human Insulin Containing Additional Disulfi..
2014 NOVO NORDISK A/S : -Tianjin and Shanghai join Cities Changing Diabetes on World ..
2014 Novo Nordisk A/S - Share repurchase programme
2014 NOVO NORDISK A/S : second best in the world at providing access to medicine
2014 NOVO NORDISK A/S : Researchers from Novo Nordisk Provide Details of New Studies ..
2014 NOVO NORDISK A/S : Research Conducted at Novo Nordisk Has Updated Our Knowledge ..
2014 NOVO NORDISK A/S : City of Houston and Novo Nordisk Partner to Lead Fight Agains..
2014 NOVO NORDISK A/S : High number of diabetics causes alarm
2014 NOVO NORDISK A/S : Share repurchase programme
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF